363 related articles for article (PubMed ID: 18573422)
1. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
Bharat A; Kuo E; Steward N; Aloush A; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
[TBL] [Abstract][Full Text] [Related]
2. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
[TBL] [Abstract][Full Text] [Related]
3. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
Bharat A; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
Ann Thorac Surg; 2010 Oct; 90(4):1094-101. PubMed ID: 20868794
[TBL] [Abstract][Full Text] [Related]
5. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
Haynes LD; Julliard WA; Mezrich JD; Leverson G; Meyer KC; Burlingham WJ
Transplantation; 2018 Jul; 102(7):1132-1138. PubMed ID: 29360666
[TBL] [Abstract][Full Text] [Related]
6. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
[TBL] [Abstract][Full Text] [Related]
8. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
[TBL] [Abstract][Full Text] [Related]
9. HLA and lung transplantation.
Ju L; Suberbielle C; Li X; Mooney N; Charron D
Front Med; 2019 Jun; 13(3):298-313. PubMed ID: 29974325
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
11. Increased lung allograft failure in patients with HLA-specific antibody.
Girnita AL; McCurry KR; Zeevi A
Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
Park JE; Kim CY; Park MS; Song JH; Kim YS; Lee JG; Paik HC; Kim SY
BMC Pulm Med; 2018 Mar; 18(1):45. PubMed ID: 29529999
[TBL] [Abstract][Full Text] [Related]
14. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
[TBL] [Abstract][Full Text] [Related]
15. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
Lobo LJ; Aris RM; Schmitz J; Neuringer IP
J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for immune regulation after human lung transplantation.
Mohanakumar T; Sharma M; Bansal S; Ravichandran R; Smith MA; Bremner RM
J Thorac Cardiovasc Surg; 2019 May; 157(5):2096-2106. PubMed ID: 31288367
[TBL] [Abstract][Full Text] [Related]
18. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.
Saini D; Angaswamy N; Tiriveedhi V; Fukami N; Ramachandran S; Hachem R; Trulock E; Meyers B; Patterson A; Mohanakumar T
J Heart Lung Transplant; 2010 Dec; 29(12):1330-6. PubMed ID: 20691611
[TBL] [Abstract][Full Text] [Related]
20. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
